Ðí¶àÈËÒÔΪ£¬µÃÉö½áʯ½ö½öÊÇÓÉÓÚË®ºÈµÃÌ«ÉÙ¡¢Òûʳ²»¼ÍÂÉ¡£ËäÈ»ÕâЩȷʵÊÇÖ÷ÒªÔµ¹ÊÔÓÉ£¬µ«Äã¿ÉÄܲ»ÖªµÀ£ºÒÅ´«ÒòËØÔÚÉö½áʯµÄ±¬·¢ÖÐÒ²ÊÎÑÝ×ÅÒªº¦½ÇÉ«¡£ÕâÀàÈ˵Ľáʯ£¬ÐèÒªÏà¶ÔÓ¦µÄÖÎÁÆÒªÁ죬²»Êǵ¥¿¿¶àºÈË®¾ÍÄܽâ¾öµÄ¡£Í¨¹ý»ùÒò¼ì²âÕÒµ½ÒÅ´«Ñ§²¡Òò£¬¾ÍÄÜ×ÊÖúÁÙ´²Ò½ÉúÑ¡ÔñºÏÊʵÄÖÎÁÆ·½·¨¡£

Éö½áʯҲ¿ÉÄÜÒÅ´«£¡
»ùÒò¼ì²âÄܲé³öʲô£¿
»ùÒò¼ì²â¾ÍÏñ¸øÉíÌå×öÒ»´Î¡°É¨Ã衱£¬¿´¿´ÊÇÄĸö¡°»ùÒòÁã¼þ¡±³öÁËÎÊÌ⣬µ¼ÖÂÉíÌåÈÝÒ׳¤½áʯ¡£²î±ðµÄ»ùÒòÎÊÌ⣬µ¼ÖµĽáʯÀàÐͼ°ÆäÖÎÁƼƻ®ÍêÈ«²î±ð[4]£º

ÓÐÁË»ùÒò¼ì²âЧ¹û£¬¾Í¿ÉÒÔÖ±»÷Òªº¦£¬ÖúÁ¦¾«×¼ÖÎÁÆ¡¢¸´·¢ÆÀ¹À¡¢ÔçÆÚ¸ÉÔ¤£º
Ã÷È··Ö×Ó²¡Òò£¬Ö¸µ¼¾«×¼ÖÎÁÆ
ÈçÉϱíËùʾ£¬²î±ð»ùÒò±äÒìËùÖÂÉö½áʯµÄÖÎÁƼƻ®²î±ðÏÔÖø£¬»ùÒò¼ì²â¿É×èÖ¹ÂÄÀúÐÔÖÎÁÆ£¬ÌáÉýÖÎÁÆÐ§¹û¡£
ÆÀ¹À¸´·¢Î£º¦£¬Öƶ©¸öÌ廯Ԥ·À¼Æ»®
ͨ¹ý»ùÒò·ÖÐÍÃ÷È·»¼Õß·¢²¡»úÖÆ£¬¿ÉÕë¶ÔÐÔÖÆ¶©ÒûË®¡¢Òûʳ¡¢Ò©Îï¸ÉÔ¤µÈÔ¤·ÀÕ½ÂÔ£¬½µµÍ½áʯ¸´·¢¸ÅÂÊ¡£
Ìṩ¼Ò×åÒÅ´«×Éѯ£¬ÊµÏÖÔçÆÚ¸ÉÔ¤
Ã÷È·Ö²¡»ùÒòºó£¬¿É¶Ô»¼Õß¼ÒÍ¥³ÉÔ±¾ÙÐÐΣº¦É¸²é£¬¶ÔЯ´øÖ²¡»ùÒòµÄÖ§Êô¾ÙÐÐÔçÆÚ¸ÉÔ¤£¬ïÔ̼Ò×åÄÚ¼²²¡Èº¼¯±¬·¢¡£
ÄÄЩÈ˽¨Òé×öÉö½áʯ»ùÒò¼ì²â£¿
²»ÊÇÿ¸ö½áʯ»¼Õß¶¼ÐèÒª×ö»ùÒò¼ì²â¡£µ«ÈôÊÇÄãÇкÏÏÂÃæÈκÎÒ»Ìõ£¬¾ÍÖµµÃÈÏÕæË¼Á¿£º
01¡¢ÄêËêÇáÇá¾ÍµÃ½áʯ£º²»µ½25Ëê¾Í·¢²¡£¬ÓÈÆäÊǶùͯ»òÇàÉÙÄêʱÆÚ¡£
02¡¢½áÊ¯ÖØ¸´±¬·¢£ºËéʯ»òÅÅʯºó£¬¶ÌÆÚÄÚÓÖ³¤³öнáʯ¡£
03¡¢¼ÒÀïÓÐÈ˵ùý½áʯ£ºâïÊÑ¡¢ÐֵܽãÃÃÖÐÒ²ÓÐÉö½áʯ»¼Õß¡£
04¡¢½áʯÒòËØÌØÊ⣺ºÃ±Èë×°±Ëá½áʯ¡¢²ÝËá¸Æ½áʯµÈÉÙ¼ûÀàÐÍ¡£
05¡¢°éÓÐÆäËûÉíÌåÎÊÌ⣺ºÃ±ÈÉöË¥½ß¡¢¶úÁû¡¢ÊÓÁ¦Òì³£¡¢·¢Óý»ºÂýµÈ¡£
ÕâЩÇéÐÎÌáÐÑ£ºÄãµÄ½áʯ¿ÉÄܲ»ÊÇ¡°ºóÌìϰ¹ß¡±Ôì³ÉµÄ£¬¶øÊÇ¡°ÏÈÌì»ùÒò¡±¾öÒéµÄ¡£
»ùÒò¡°ÑÏÑ¡¡±£¬ÖúÁ¦Éö½áʯ¾«×¼ÕïÁÆ
×ðÁú¿Ê±ÁÙ´²»ùÒò×éÖÐÐľ߱¸³ÉÊìµÄ¸ßͨÁ¿²âÐò¼ì²âϵͳ¡¢Ò»´ú²âÐòƽ̨µÈÇ°ÑØ¼ì²âƽ̨£¬×¨ÒµµÄÉúÎïÐÅϢѧÆÊÎöÍŶӼ°ÂÄÀú¸»ºñµÄÒÅ´«×ÉѯʦÍŶӣ¬Æä¿ª·¢µÄ»ùÓÚÏÂÒ»´ú²âÐò£¨NGS£©ÊÖÒյİÐÏò»ùÒòpanel£¬¾ßÓиßЧ¡¢¾«×¼¡¢¾¼ÃµÄÓÅÊÆ£¬¿É¿ìËÙ¼ì²âÓëÉö½áʯÏà¹ØµÄÖ²¡»ùÒò£¬ÎªÁÙ´²¾«×¼Õï¶Ï¡¢ÖÎÁƼ°Ô¤·ÀÌṩÓÐÁ¦Ö§³Ö£¬ÖúÁ¦Éö½áʯÕïÁƽøÈ뾫׼»¯Ê±´ú¡£
¸Ãpanel¾Û½¹ÒÔÉö½áʯΪÖ÷Òª»òΨһÁÙ´²ÌåÏֵĵ¥»ùÒòÒÅ´«²¡£¬ÁýÕÖ40Óà¸öÏà¹Ø»ùÒò£¬ÖúÁ¦¿ìËÙÃ÷È·½¹µãÖ²¡Ôµ¹ÊÔÓÉ£¬ÊÊÓÃÓÚÁÙ´²¸ß¶ÈÏÓÒÉÒÅ´«ÐÔ½áʯµÄ»¼Õß¡£
PanelÖеĻùÒòÄÉÈë±ê×¼£º
1¡¢OMIMÊý¾Ý¿âÖÐÃ÷È·ÒÔ¡°Éö½áʯ¡±¡°Éö¸ÆÖÊÀä¾²Ö¢¡±ÎªÖ÷ÒªÁÙ´²±íÐ͵ÄÖ²¡»ùÒò£»£¨OMIM£ºÔÚÏß¡¶ÈËÀàÃϵ¶ûÒÅ´«¡·Online Mendelian Inheritance in Man£©
2¡¢º£ÄÚÍâÎÄÏׯձ鱍µÀµÄÉö½áʯÏà¹ØÈÈÃÅÖ²¡»ùÒò£¬º¸Çë×°±ËáÄòÖ¢¡¢Ô·¢ÐԸ߲ÝËáÄòÖ¢¡¢Dent²¡µÈ³£¼ûÒÅ´«ÐÔ½áʯ¼²²¡Ïà¹Ø»ùÒò¡£
¼ì²âµÄ»ùÒòÁÐ±í£º
1¡¢ë×°±ËáÄòÖ¢Ïà¹Ø£ºSLC7A9¡¢SLC3A1£»
2¡¢Ô·¢ÐԸ߲ÝËáÄòÖ¢Ïà¹Ø£ºAGXT¡¢GRHPR¡¢HOGA1£»
3¡¢¸ß¸ÆÄòÖ¢Ïà¹Ø£ºSLC34A1¡¢SLC34A3¡¢CYP24A1¡¢CLDN16¡¢CLDN19£»
4¡¢ÉöС¹ÜËáÖж¾Ïà¹Ø£ºSLC4A1¡¢ATP6V0A4¡¢ATP6V1B1£»
5¡¢ÆäËûÏà¹Ø£ºXDH£¨»ÆàÑßÊÄòÖ¢£©¡¢APRT£¨2,8-¶þôÇ»ùÏÙàÑßʽáʯ£©¡¢CLCN5¡¢OCRL£¨Dent²¡£©µÈ¡£

²Î¿¼ÎÄÏ×
1. Pintus F, Giordano N, Giachino DF, Mandrile G. Genetics of kidney stones and the role of genetic testing in prevention: a guide for urologists. Front Med (Lausanne). 2025 Jul 25;12:1631281. doi: 10.3389/fmed.2025.1631281. PMID: 40786091; PMCID: PMC12331670.
2. Halbritter J, Baum M, Hynes AM, Rice SJ, Thwaites DT, Gucev ZS, Fisher B, Spaneas L, Porath JD, Braun DA, Wassner AJ, Nelson CP, Tasic V, Sayer JA, Hildebrandt F. Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis. J Am Soc Nephrol. 2015 Mar;26(3):543-51. doi: 10.1681/ASN.2014040388. Epub 2014 Oct 8. PMID: 25296721; PMCID: PMC4341487.
3. Wu CW, Huang YR, Bodner D, Schumacher FR, Baum M, Hildebrandt F. The evolving landscape of monogenic nephrolithiasis and therapeutic innovations. Nat Rev Urol. 2024 Sep;21(9):513-514. doi: 10.1038/s41585-024-00880-0. PMID: 38632353; PMCID: PMC11648848.
4. Howles SA£¬Thakker RV¡£Éö½áʯ²¡µÄÒÅ´«Ñ§¡£Nat Rev Urol¡£2020Äê7ÔÂ; 17(7):407-421. DOI£º10.1038/s41585-020-0332-x¡£µç×Ó³öÊé 2020Äê6ÔÂ12ÈÕ¡£PMID£º32533118¡£